Supernus Pharmaceuticals, Inc(NASDAQ:SUPN) 
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. Its commercial products include Trokendi XR, an extended release topiramate product indicated for the t...
Website: http://www.supernus.com
Founded: 2005
Full Time Employees: 464
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 31.68
H 33.35
L 31.43
C 32.74
V 1,501,832
10EMA 32.74
20EMA 32.74
60EMA 32.74
120EMA 32.74
250EMA 32.74